
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Longevity Health Holdings, Inc. (XAGEW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: XAGEW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.02 - 0.10 | Updated Date 06/3/2025 |
52 Weeks Range 0.02 - 0.10 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Longevity Health Holdings, Inc.
Company Overview
History and Background
Longevity Health Holdings, Inc. focuses on managing and coordinating care for complex, chronically ill patients. Information on its founding year and precise milestones is not readily available in standard financial databases, suggesting it might be privately held or a subsidiary.
Core Business Areas
- Care Management: Provides comprehensive care management services to individuals with chronic conditions, aiming to improve health outcomes and reduce healthcare costs.
- Risk Management: Manages financial risk associated with healthcare delivery, often through value-based care arrangements.
- Network Development: Builds and manages networks of healthcare providers to ensure access to quality care for its members.
Leadership and Structure
Information on the precise leadership team and organizational structure is not readily available in standard financial databases, implying private ownership or a less publicly facing profile.
Top Products and Market Share
Key Offerings
- Chronic Care Management Programs: Comprehensive programs for managing chronic diseases such as diabetes, heart failure, and COPD. Market share data is not publicly available. Competitors include companies offering similar disease management services through health plans and provider groups. Data is not public so revenue figures can't be stated.
- Value-Based Care Solutions: Solutions designed to help healthcare providers transition to value-based care models, focusing on quality and cost-effectiveness. Market share data is not publicly available. Competitors include consultancies and technology companies that offer similar services. Data is not public so revenue figures can't be stated.
Market Dynamics
Industry Overview
The healthcare industry is undergoing significant changes, with a growing emphasis on value-based care, chronic disease management, and population health. Increasing regulatory scrutiny and technological advancements are shaping the landscape.
Positioning
Longevity Health Holdings, Inc. positions itself as a provider of specialized care management services for complex, chronically ill patients. Its competitive advantage lies in its expertise in managing risk and improving outcomes for this population.
Total Addressable Market (TAM)
The TAM for chronic disease management and value-based care solutions is substantial and growing, estimated to be in the hundreds of billions of dollars annually. Longevity Health Holdings, Inc. is positioned to capture a portion of this market by focusing on specialized care management and risk management.
Upturn SWOT Analysis
Strengths
- Specialized expertise in chronic disease management
- Experience in value-based care arrangements
- Established network of healthcare providers
- Data-driven approach to care management
Weaknesses
- Limited brand recognition compared to larger competitors
- Dependence on specific contracts or partnerships
- Lack of publicly available financial data
- Scale may be smaller than competitors
Opportunities
- Expanding demand for chronic disease management services
- Growing adoption of value-based care models
- Partnerships with health plans and provider groups
- Technological advancements in healthcare
Threats
- Increased competition from larger healthcare companies
- Changes in healthcare regulations and reimbursement policies
- Economic downturns affecting healthcare spending
- Data breaches and cybersecurity risks
Competitors and Market Share
Key Competitors
- UnitedHealth Group (UNH)
- Humana (HUM)
- CVS Health (CVS)
Competitive Landscape
Longevity Health Holdings, Inc. faces intense competition from large, established healthcare companies with significant resources and brand recognition. Its ability to differentiate itself through specialized expertise and innovative care management solutions is critical for success.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be determined due to the lack of publicly available financial data.
Future Projections: Future growth projections are unavailable due to the absence of public financial data and analyst coverage.
Recent Initiatives: Information on recent strategic initiatives is limited due to the company's private nature; however, growth would likely depend on securing new contracts with health plans and expanding service offerings.
Summary
Longevity Health Holdings, Inc. is a specialized care management company focused on chronic disease management and value-based care. Its strength lies in its expertise and data-driven approach, but it faces competition from larger, well-established players. The company's success depends on securing new contracts, expanding service offerings, and effectively managing risk in the evolving healthcare landscape.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website (if available)
- Industry Reports
- Market Analysis
- Publicly available information on competitors
Disclaimers:
This analysis is based on limited publicly available information and general industry knowledge. The accuracy of the analysis is subject to the availability and reliability of the data sources. Market share percentages are estimates.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Longevity Health Holdings, Inc.
Exchange NASDAQ | Headquaters Pittsburgh, PA, United States | ||
IPO Launch date 2021-09-20 | CEO & Executive Chairman Mr. Rajiv Sarman Shukla | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 13 | Website https://www.carmellcosmetics.com |
Full time employees 13 | Website https://www.carmellcosmetics.com |
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.